A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 104,900 shares of INSP stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104,900
Previous 72,500 44.69%
Holding current value
$14 Million
Previous $14.7 Million 52.77%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.3 - $226.0 $14.7 Million - $20 Million
88,706 Added 2070.15%
92,991 $20 Million
Q4 2023

Feb 14, 2024

SELL
$125.26 - $203.83 $5.61 Million - $9.12 Million
-44,767 Reduced 91.26%
4,285 $871,000
Q3 2023

Nov 14, 2023

SELL
$185.0 - $326.08 $50.1 Million - $88.2 Million
-270,620 Reduced 84.66%
49,052 $9.73 Million
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $3.28 Million - $4.69 Million
14,460 Added 4.74%
319,672 $104 Million
Q1 2023

May 15, 2023

SELL
$229.06 - $278.01 $74.9 Million - $90.9 Million
-327,118 Reduced 51.73%
305,212 $71.4 Million
Q4 2022

Feb 14, 2023

BUY
$164.02 - $259.76 $13.6 Million - $21.5 Million
82,864 Added 15.08%
632,330 $159 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $40.8 Million - $54.1 Million
238,946 Added 76.95%
549,466 $97.5 Million
Q2 2022

Aug 15, 2022

BUY
$147.53 - $266.6 $35 Million - $63.2 Million
237,060 Added 322.71%
310,520 $56.7 Million
Q1 2022

May 16, 2022

SELL
$193.94 - $261.91 $38.3 Million - $51.7 Million
-197,226 Reduced 72.86%
73,460 $18.9 Million
Q4 2021

Feb 14, 2022

BUY
$207.57 - $280.17 $37.3 Million - $50.4 Million
179,825 Added 197.91%
270,686 $62.3 Million
Q3 2021

Nov 15, 2021

SELL
$170.0 - $258.58 $33.8 Million - $51.3 Million
-198,533 Reduced 68.6%
90,861 $21.2 Million
Q2 2021

Aug 16, 2021

BUY
$164.93 - $242.23 $39 Million - $57.2 Million
236,335 Added 445.42%
289,394 $55.9 Million
Q1 2021

May 17, 2021

BUY
$182.45 - $249.25 $3.17 Million - $4.34 Million
17,393 Added 48.77%
53,059 $11 Million
Q4 2020

Feb 16, 2021

BUY
$119.35 - $200.46 $1.38 Million - $2.32 Million
11,588 Added 48.13%
35,666 $6.71 Million
Q3 2020

Nov 16, 2020

BUY
$87.5 - $130.91 $1.85 Million - $2.78 Million
21,198 Added 736.04%
24,078 $3.11 Million
Q2 2020

Aug 14, 2020

SELL
$49.5 - $97.93 $3.04 Million - $6.02 Million
-61,474 Reduced 95.52%
2,880 $251,000
Q1 2020

May 15, 2020

BUY
$41.62 - $89.92 $1.58 Million - $3.42 Million
38,029 Added 144.46%
64,354 $3.88 Million
Q4 2019

Feb 14, 2020

SELL
$52.12 - $75.0 $2.3 Million - $3.31 Million
-44,090 Reduced 62.61%
26,325 $1.95 Million
Q3 2019

Nov 14, 2019

SELL
$61.02 - $70.19 $13 Million - $14.9 Million
-212,873 Reduced 75.14%
70,415 $4.3 Million
Q2 2019

Aug 14, 2019

SELL
$47.07 - $60.71 $4.27 Million - $5.51 Million
-90,692 Reduced 24.25%
283,288 $17.2 Million
Q1 2019

May 15, 2019

BUY
$39.48 - $62.0 $10.1 Million - $15.9 Million
256,600 Added 218.61%
373,980 $0
Q4 2018

Feb 14, 2019

SELL
$37.07 - $52.58 $2.72 Million - $3.85 Million
-73,256 Reduced 38.43%
117,380 $4.96 Million
Q3 2018

Nov 13, 2018

BUY
$36.8 - $56.99 $5.81 Million - $9 Million
157,844 Added 481.35%
190,636 $0
Q2 2018

Aug 10, 2018

BUY
$24.05 - $39.5 $788,647 - $1.3 Million
32,792 New
32,792 $0

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $3.85B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.